Clinical trials in Vilnius – page 3

188 clinical trials in Vilnius, Lithuania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in LithuaniaKlinikiniai-Tyrimai.lt

Vilnius at a glance

188

clinical trials

Research sites3

Quick filters

188 trials in Vilnius

Open in trial search

Major depression

Recruiting

InvestigationalNo placebo

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo

Lithuania

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
Sponsor:Neurocrine Biosciences Inc.

Contact Research Centre

Immune thrombocytopenia

Recruiting

Investigational

Study of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia

Investigational

Lithuania

Participants:0–17 years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Hypertriglyceridaemia

Recruiting

Investigational

Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Acromegaly

Recruiting

Registered drug

Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

Registered drug

Lithuania

Participants:18–64 years · 65+ years
Substances:Lanreotide
Sponsor:Debiopharm International SA

Contact Research Centre

Major depression

Recruiting

Investigational

Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
Sponsor:Neurocrine Biosciences Inc.

Contact Research Centre

Ischaemic stroke

Recruiting

Investigational

Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:JX10
Sponsor:Corxel Pharmaceuticals Co. Ltd.

Contact Research Centre

Cardiac failure chronic+1

Recruiting

Registered drugNo placebo

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Lithuania

Participants:18–64 years · 65+ years
Substances:Ferric Derisomaltose
Sponsor:Pharmacosmos A/S

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drug

Lithuania

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Anaemia+1

Recruiting

Investigational

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:Elritercept
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Lupus nephritis

Recruiting

Registered drugNo placebo

Study on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment

Registered drugNo placebo

Lithuania

Participants:18–64 years · 65+ years
Substances:Emtricitabine
Sponsor:Novartis Pharma AG

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drug

Lithuania

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Neurogenic bladder

Recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

InvestigationalNo placebo

Lithuania

Participants:0–17 years
Substances:Vibegron
Sponsor:Sumitomo Pharma America Inc.

Contact Research Centre

Other cities in Lithuania

The busiest research cities in the country

All 10 cities in Lithuania

Clinical research in Vilnius

What the registry says about research in the country

01 Respiratory Medicine

Innovative research focusing on lung cancer treatments and respiratory conditions, including multiple trials for advanced NSCLC and studies examining new therapies for asthma management.

Non-small cell lung cancer treatments
Asthma control therapies
Small cell lung cancer interventions

Studies combine immunotherapy approaches with traditional treatments to improve patient outcomes.

02 Autoimmune Conditions

Comprehensive research into various autoimmune disorders, including Sjögren's syndrome, systemic lupus erythematosus, and inflammatory conditions.

Crohn's disease treatments
Rheumatoid arthritis therapies
Novel biological treatments

Trials focus on developing targeted therapies to manage chronic autoimmune conditions.

03 Hematology & Oncology

Advanced research in blood disorders and cancers, including studies on acute myeloid leukemia and myelodysplastic syndromes.

Leukemia treatments
Anemia therapies
Blood cancer interventions

Investigations include both pediatric and adult populations with various blood disorders.

Back to Lithuania All countries